Kim, W. R. Et Al. 2013. LONG TERM TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY AND THE RISK OF HEPATOCELLULAR CARCINOMA. International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL) , (Amsterdam, Netherlands).

Kim, W. R., Berg, T., Loomba, R., Schall, R. A., Dinh, P., Yee, L. J., ... Martins, E. B.(2013). LONG TERM TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY AND THE RISK OF HEPATOCELLULAR CARCINOMA . International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Netherlands

Kim, W. Et Al. "LONG TERM TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY AND THE RISK OF HEPATOCELLULAR CARCINOMA," International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Netherlands, 2013

Kim, W. R. Et Al. "LONG TERM TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY AND THE RISK OF HEPATOCELLULAR CARCINOMA." International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL) , Amsterdam, Netherlands, 2013

Kim, W. R. Et Al. (2013) . "LONG TERM TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY AND THE RISK OF HEPATOCELLULAR CARCINOMA." International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL) , Amsterdam, Netherlands.

@conferencepaper{conferencepaper, author={W. R. Kim Et Al. }, title={LONG TERM TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY AND THE RISK OF HEPATOCELLULAR CARCINOMA}, congress name={International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL)}, city={Amsterdam}, country={Netherlands}, year={2013}}